Literature DB >> 27497068

Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.

Joshua Sullivan1, Bryan Paul Jett2, Mark Cradick3, Jeffrey Zuber4.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (T2DM), if left uncontrolled, is associated with significant morbidity and mortality. Patients in rural areas may not have access to adequate resources to successfully treat diabetes. Clinical pharmacists may be utilized to bridge this gap.
OBJECTIVE: To evaluate the impact of a clinical pharmacist on glycemic control in veterans with T2DM enrolled in a rural, outpatient clinic.
METHODS: Retrospective chart review was performed on veterans with T2DM referred to the pharmacist-managed therapeutic monitoring clinic at a community-based outpatient clinic located in rural Jackson, TN. Patients served as their own controls. Patients with hemoglobin A1C (A1C) ≥8% were included. The primary outcome was A1C change from baseline in patients managed by the clinical pharmacist. Secondary end points included blood pressure, cholesterol, and weight.
RESULTS: Of 111 veterans identified as having a A1C ≥8% in the pharmacist-managed clinic, 86 met inclusion criteria. At baseline, mean ± SD A1C was 10.5% ± 2.0% (range = 8.7%-16.2%). By the end of the intervention period, mean A1C had decreased by 2.8 percentage points to 7.7% ± 1.4% (P < 0.001). At the end of the intervention, 34% (n = 29) had a A1C of <7%, 40% (n = 34) between 7% and 7.9%, and only 6% (n = 5) >10% (P < 0.001). Improvements in diastolic blood pressure (P = 0.001), total cholesterol (P = 0.001), and triglyceride levels (P = 0.036) were also statistically significant when baseline and intervention period values were compared.
CONCLUSION: Pharmacist interventions at a rural, outpatient clinic had a statistically significant impact on A1C reduction in veterans with T2DM.
© The Author(s) 2016.

Entities:  

Keywords:  ambulatory care; clinical pharmacy; pharmaceutical care; therapeutic monitoring; type 2 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27497068     DOI: 10.1177/1060028016663564

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

1.  Impact of pharmacy services on initial clinical outcomes and medication adherence among veterans with uncontrolled diabetes.

Authors:  Justin D Gatwood; Marie Chisholm-Burns; Robert Davis; Fridtjof Thomas; Praveen Potukuchi; Adriana Hung; M Shawn McFarland; Csaba P Kovesdy
Journal:  BMC Health Serv Res       Date:  2018-11-14       Impact factor: 2.655

Review 2.  Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist.

Authors:  Dhiren Patel; Curtis Triplitt; Jennifer Trujillo
Journal:  Adv Ther       Date:  2019-03-21       Impact factor: 3.845

3.  Evaluation of a clinical pharmacist team-based telehealth intervention in a rural clinic setting: a pilot study of feasibility, organizational perceptions, and return on investment.

Authors:  Logan T Murry; Christopher P Parker; Rachel J Finkelstein; Matthew Arnold; Korey Kennelty
Journal:  Pilot Feasibility Stud       Date:  2020-09-10

Review 4.  Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes.

Authors:  Amanda Wojtusik Orabone; Vincent Do; Elizabeth Cohen
Journal:  Diabetes Metab Syndr Obes       Date:  2022-06-20       Impact factor: 3.249

5.  Retrospective Comparison of Appropriate Statin Use Between Patients With Diabetes in the Primary Care Setting Managed by Pharmacists or Internal Medicine Providers.

Authors:  Jamie M Huff; Rebecca A Falter; Nataliya Scheinberg
Journal:  Diabetes Spectr       Date:  2019-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.